Attend Q1 Productions Life Science Regulatory Intelligence Conference
Event Highlights: Perspectives of payers on diagnostic evidence and access Evidence targets for increasing coverage through laboratory benefit management Defining diagnostic value relative to costs for payer networks: generating and applying clinical evidence Increased need for prior authorizations has an impact. Impact of changing health policies on test coverage and reimbursement Q1 Life Science Regulatory Intelligence Conference brings together specialists from around the world in the fields of global intelligence, strategy, policy, and law to share best practices on regulatory concerns. Examine how your peers inform internal stakeholders about regulatory changes and competitive intelligence, provide feedback on submissions, and comment…
